Search research articles
Contact Us
Filters
Showing results (61-70 of 125) with videos related to
Page
of 13
Sort By:
Genomics
|
May 7, 2002
A partial transcriptome of human epidermis
Fred van Ruissen, Bastiaan J H Jansen, Gys J de Jongh, et al.
Journal of Affective Disorders
|
October 1, 1991
Can winter depression be prevented by light treatment?
Y Meesters, P A Lambers, J H Jansen, et al.
Journal of Affective Disorders
|
July 1, 1993
Morning and evening light treatment of seasonal affective disorder: response, relapse and prediction
Y Meesters, J H Jansen, P A Lambers, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
December 17, 2020
[Clonal hematopoiesis: a risk factor for leukemia and cardiovascular disease?]
I A van Zeventer, S C Buisman, A O de Graaf, et al.
Blood
|
December 18, 2002
Mac-1 (CD11b/CD18) is crucial for effective Fc receptor-mediated immunity to melanoma
Annemiek B van Spriel, Heidi H van Ojik, Annie Bakker, et al.
The Journal of Investigative Dermatology
|
December 17, 2003
Tumor necrosis factor related apoptosis inducing ligand triggers apoptosis in dividing but not in differentiating human epidermal keratinocytes
Bastiaan J H Jansen, Fred van Ruissen, Stefanie Cerneus, et al.
The New England Journal of Medicine
|
February 27, 1992
Response to interferon alfa-2b in a patient with systemic mastocytosis
H C Kluin-Nelemans, J H Jansen, H Breukelman, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
January 5, 2002
Differential gene expression in premalignant human epidermis revealed by cluster analysis of serial analysis of gene expression (SAGE) libraries
Fred van Ruissen, Bastiaan J H Jansen, Gys J de Jongh, et al.
Leukemia
|
March 1, 1991
A new non-Hodgkin's B-cell line (DoHH2) with a chromosomal translocation t(14;18)(q32;q21)
H C Kluin-Nelemans, J Limpens, J Meerabux, et al.
British Journal of Haematology
|
November 25, 2000
Molecular remission of Philadelphia/bcr-abl-positive acute myeloid leukaemia after treatment with anti-CD33 calicheamicin conjugate (gemtuzumab ozogamicin, CMA-676)
M P de Vetten, J H Jansen, B A van der Reijden, et al.
Page
of 13
Search research articles
Search
Showing results (61-70 of 125) with videos related to
Sort By:
Page
of 13
Genomics
|
May 7, 2002
A partial transcriptome of human epidermis
Fred van Ruissen, Bastiaan J H Jansen, Gys J de Jongh, et al.
Journal of Affective Disorders
|
October 1, 1991
Can winter depression be prevented by light treatment?
Y Meesters, P A Lambers, J H Jansen, et al.
Journal of Affective Disorders
|
July 1, 1993
Morning and evening light treatment of seasonal affective disorder: response, relapse and prediction
Y Meesters, J H Jansen, P A Lambers, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
December 17, 2020
[Clonal hematopoiesis: a risk factor for leukemia and cardiovascular disease?]
I A van Zeventer, S C Buisman, A O de Graaf, et al.
Blood
|
December 18, 2002
Mac-1 (CD11b/CD18) is crucial for effective Fc receptor-mediated immunity to melanoma
Annemiek B van Spriel, Heidi H van Ojik, Annie Bakker, et al.
The Journal of Investigative Dermatology
|
December 17, 2003
Tumor necrosis factor related apoptosis inducing ligand triggers apoptosis in dividing but not in differentiating human epidermal keratinocytes
Bastiaan J H Jansen, Fred van Ruissen, Stefanie Cerneus, et al.
The New England Journal of Medicine
|
February 27, 1992
Response to interferon alfa-2b in a patient with systemic mastocytosis
H C Kluin-Nelemans, J H Jansen, H Breukelman, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
January 5, 2002
Differential gene expression in premalignant human epidermis revealed by cluster analysis of serial analysis of gene expression (SAGE) libraries
Fred van Ruissen, Bastiaan J H Jansen, Gys J de Jongh, et al.
Leukemia
|
March 1, 1991
A new non-Hodgkin's B-cell line (DoHH2) with a chromosomal translocation t(14;18)(q32;q21)
H C Kluin-Nelemans, J Limpens, J Meerabux, et al.
British Journal of Haematology
|
November 25, 2000
Molecular remission of Philadelphia/bcr-abl-positive acute myeloid leukaemia after treatment with anti-CD33 calicheamicin conjugate (gemtuzumab ozogamicin, CMA-676)
M P de Vetten, J H Jansen, B A van der Reijden, et al.
Page
of 13